What does CUSIP 09058V103 represent in this 13F holders report?

CUSIP 09058V103 is the security identifier for BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in Q2 2018?

98 institutional investors reported BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX)

CUSIP: 09058V103

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 251,185,504
Total 13F shares: 87,486,065
Share change: -1,581,501
Total reported value: $501,300,833
Put/Call ratio: 44%
Price per share: $5.73
Number of holders: 98
Value change: -$8,812,924
Number of buys: 34
Number of sells: 44

Quarterly Holders Quick Answers

What is CUSIP 09058V103?
CUSIP 09058V103 identifies BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 09058V103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BAKER BROS. ADVISORS LP	13F	Company	5.6%	14,012,172	$66,838,000	—	31 Mar 2018	13F
JANUS HENDERSON GROUP PLC	13F	Company	3%	7,654,685	$36,513,000	—	31 Mar 2018	13F
GREAT POINT PARTNERS LLC	13F	Company	3%	7,478,275	$35,671,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	3%	7,474,419	$35,653,000	—	31 Mar 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	2.9%	7,366,460	$35,138,000	—	31 Mar 2018	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	2.8%	6,984,692	$33,317,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	2.3%	5,665,757	$27,026,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	1.8%	4,504,714	$21,494,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	1.8%	4,418,631	$21,077,000	—	31 Mar 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	1.4%	3,504,595	$16,717,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.1%	2,690,255	$12,833,000	—	31 Mar 2018	13F
VHCP Management II, LLC	13F	Company	0.88%	2,220,971	$10,594,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.47%	1,188,876	$5,671,000	—	31 Mar 2018	13F
DAFNA Capital Management LLC	13F	Company	0.39%	974,652	$4,649,000	—	31 Mar 2018	13F
D. E. Shaw & Co., Inc.	13F	Company	0.38%	964,306	$4,600,000	—	31 Mar 2018	13F
Invesco Ltd.	13F	Company	0.37%	941,651	$4,491,000	—	31 Mar 2018	13F
Rock Springs Capital Management LP	13F	Company	0.37%	925,000	$4,412,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.37%	920,734	$4,390,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.35%	877,651	$4,186,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.31%	767,803	$3,662,000	—	31 Mar 2018	13F
Hudson Bay Capital Management LP	13F	Company	0.22%	560,000	$2,671,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.22%	548,146	$2,615,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.2%	490,976	$2,342,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.18%	462,370	$2,205,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.18%	462,079	$2,204,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.18%	441,431	$2,106,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.13%	330,731	$1,578,000	—	31 Mar 2018	13F
ClariVest Asset Management LLC	13F	Company	0.12%	295,166	$1,409,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.12%	291,379	$1,390,000	—	31 Mar 2018	13F
TEACHERS ADVISORS, LLC	13F	Company	0.11%	271,137	$1,293,000	—	31 Mar 2018	13F
Allianz Asset Management GmbH	13F	Company	0.09%	231,761	$1,105,000	—	31 Mar 2018	13F
Swiss National Bank	13F	Company	0.07%	171,300	$817,000	—	31 Mar 2018	13F
VIRTUS ADVISERS, LLC	13F	Company	0.06%	154,147	$735,000	—	31 Mar 2018	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	149,223	$712,000	—	31 Mar 2018	13F
Eversept Partners, LP	13F	Company	0.06%	148,959	$710,534	—	31 Mar 2018	13F
ROYCE & ASSOCIATES LP	13F	Company	0.06%	144,000	$687,000	—	31 Mar 2018	13F
CITIGROUP INC	13F	Company	0.06%	138,702	$662,000	—	31 Mar 2018	13F
ALPS ADVISORS INC	13F	Company	0.05%	132,021	$630,000	—	31 Mar 2018	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.05%	118,300	$564,000	—	31 Mar 2018	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.05%	116,320	$555,000	—	31 Mar 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.04%	101,800	$486,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.04%	100,409	$479,000	—	31 Mar 2018	13F
Cheyne Capital Management (UK) LLP	13F	Company	0.04%	100,000	$477,000	—	31 Mar 2018	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.04%	93,800	$447,000	—	31 Mar 2018	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	91,745	$438,000	—	31 Mar 2018	13F
CREDIT SUISSE AG/	13F	Company	0.03%	85,968	$411,000	—	31 Mar 2018	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.03%	75,505	$360,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.03%	68,052	$324,000	—	31 Mar 2018	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.02%	62,634	$299,000	—	31 Mar 2018	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.02%	60,215	$287,225	—	31 Mar 2018	13F

Institutional Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) as of Q2 2018

As of 30 Jun 2018, BIOCRYST PHARMACEUTICALS INC - Common Stock (BCRX) was held by 98 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 87,486,065 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, BlackRock Inc., GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, and JENNISON ASSOCIATES LLC. This page lists 98 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.